tiprankstipranks
Circio CTO Exercises Warrants Amidst RNA Tech Advances
Company Announcements

Circio CTO Exercises Warrants Amidst RNA Tech Advances

Targovax ASA (GB:0RIS) has released an update.

Pick the best stocks and maximize your portfolio:

Circio Holding ASA has seen its Chief Technology Officer, Thomas Birkballe Hansen, exercise 46,800 warrants at a price of NOK 0.60 per share, marking a key development in the company’s stock activity. This exercise is part of a larger issuance of 13,864,852 warrants related to a rights issue from July 2024. Circio continues to advance its cutting-edge RNA technology and cancer treatment projects, which could offer significant future value.

For further insights into GB:0RIS stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks European Auto-Generated NewsdeskCircio Holding ASA Expands Share Capital Amid Therapeutics Focus
TipRanks European Auto-Generated NewsdeskCircio CEO Exercises Warrants Amid Biotech Advancements
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App